Treatment of anterior chamber fibrin following cataract surgery with tissue plasminogen activator.
Three patients who developed anterior chamber fibrinous exudates after cataract surgery were treated with tissue plasminogen activator injected into the anterior chamber. There was prompt dissolution of the fibrinous exudates and no observed complications. When fibrinous exudates occur in high-risk patients after cataract surgery, tissue plasminogen activator provides an excellent means of clearing the fibrin.
Lesser
G R
GR
Department of Ophthalmology, Henry Ford Hospital, Detroit, Michigan 48083-1214.
Osher
R H
RH
Whipple
D
D
Abrams
G W
GW
Cionni
R J
RJ
D000328:Adult; D000368:Aged; D000867:Anterior Chamber / Q000378:metabolism*; D002387:Cataract Extraction / Q000009:adverse effects*; D005122:Exudates and Transudates; D005128:Eye Diseases / Q000188:drug therapy / Q000209:etiology; D005260:Female; D005337:Fibrin / Q000378:metabolism*; D006801:Humans; D007910:Lenses, Intraocular; D008297:Male; D011183:Postoperative Complications; D011994:Recombinant Proteins / Q000008:administration & dosage; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
D011994:Recombinant Proteins; D005337:Fibrin; D010959:Tissue Plasminogen Activator